Latest Content

The evolution of IPL is not limited to its expanding role in ocular surface disease.

Catch up on the top stories in optometry during the week of August 24-28.

The findings extend prior Asian efficacy data to a diverse North American cohort for Stellest lenses.

Optometrists share advice on the best practices for ensuring students are prepared for the new school year and how clinicians can leverage the influx to grow their practice.

The agency assigned a PDUFA target action date of April 30, 2027.

Neel S. Vaidya, MD, MPH, MBA, on why keratoconus can progress aggressively in children and teens—and how early topographic screening and prompt crosslinking protect long-term vision.

Noha Ekdawi, MD, FAAP, explains why pediatric myopia demands individualized, progression-based management.

The company announced phase 2 results of a dual-action lifitegrast/perfluorohexyloctane dry eye drop alongside positive phase 1b results for BL1332, a first-in-class TRPV1 antagonist for ocular surface pain.

Teacher-led vision screening identified about 3 in 4 children with refractive error and correctly cleared most unaffected students.

This review summarizes major contact lens risks, solution-related adverse effects, higher-risk populations, and practical prevention strategies for optometric practice.

Catch up on the top stories in optometry during the week of August 17-21.

Perceived stress modestly predicted later dry eye symptoms in young adults, but significance depended on a prespecified 1-tailed test.

Carolyn Majcher, OD, FAAO, discussed the impact of the FDA's approval of the drug for wet AMD after nearly 2 decades of off-label use.